AVX vs TDY

For growth investors, Avax One Technology Ltd (AVX) is the stronger pick with 317.

0% revenue growth year-over-year, versus 7. 9% for Teledyne Technologies Incorporated (TDY). Teledyne Technologies Incorporated (TDY) offers the better valuation at 33. 4x trailing P/E (26. 2x forward), making it the more compelling value choice. Analysts rate Teledyne Technologies Incorporated (TDY) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Teledyne Technologies Incorporated (TDY) delivered a total return of +44.

7%, compared to -100. 0% for Avax One Technology Ltd (AVX). Over 10 years, the gap is even starker: TDY returned +573. 5% versus AVX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Teledyne Technologies Incorporated (TDY) is the lower-risk stock at 0.

95β versus Avax One Technology Ltd's 2. 35β — meaning AVX is approximately 149% more volatile than TDY relative to the S&P 500. On balance sheet safety, Avax One Technology Ltd (AVX) carries a lower debt/equity ratio of 24% versus 25% for Teledyne Technologies Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Avax One Technology Ltd (AVX) is pulling ahead at 317.

0% versus 7. 9% for Teledyne Technologies Incorporated (TDY). On earnings-per-share growth, the picture is similar: Avax One Technology Ltd grew EPS 96. 0% year-over-year, compared to 9. 7% for Teledyne Technologies Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Teledyne Technologies Incorporated (TDY) is the more profitable company, earning 14.

6% net margin versus -239. 7% for Avax One Technology Ltd — meaning it keeps 14. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TDY leads at 18. 8% versus -153. 2% for AVX. At the gross margin level — before operating expenses — TDY leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Teledyne Technologies Incorporated (TDY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

95), +573. 5% 10Y return). Avax One Technology Ltd (AVX) carries a higher beta of 2. 35 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TDY: +573. 5%, AVX: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AVX (Consumer Defensive) and TDY (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AVX is a small-cap high-growth stock; TDY is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.